Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.980
-0.080 (-3.88%)
At close: Oct 23, 2026, 4:00 PM EDT
1.990
+0.010 (0.51%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $143.19 million as of October 23, 2026. It is the 22,751st most valuable company in the world and the 3,822nd biggest in the United States. Its market cap has increased by 27.78% in one year.
Market Cap
143.19M
Enterprise Value
64.64M
1-Year Change
27.78%
Global Rank
Country Rank
#3,822 United States
Category
ChartMarket Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $143.19M, a decrease of -76.85%. That is a compound annual growth rate of -24.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 143.19M | 12.03% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MediWound | 157.25M |
| NovaBridge Biosciences | 154.28M |
| NervGen Pharma | 152.68M |
| Canton Strategic Holdings | 148.21M |
| Veraxa Biotech AG | 145.65M |
| Compass Therapeutics | 144.34M |
| Protara Therapeutics | 144.19M |
| Codexis | 142.36M |